Lv11
64 积分 2023-02-17 加入
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
2个月前
已完结
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor
2个月前
已完结
Therapeutic potential of targeting polo-like kinase 4
2个月前
已完结
Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
2个月前
已完结
Discovery and Evaluation of TLR-Targeted Immune Agonists
3个月前
已完结
Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach
3个月前
已完结
Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome
4个月前
已完结
The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation
4个月前
已完结
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma
4个月前
已关闭
Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review
4个月前
已完结
皖公网安备34019202002308
